Clinical Trial Update: Early Use of Vasopressin in Post-Fontan Management [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing early use of vasopressin in post-Fontan management for single-ventricle circulation; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Circulatory Perfusion Disorder
• Congenital Heart Disease
• Single Ventricle

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Circulatory Perfusion Disorder, Congenital Heart Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-07-07